Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-02-11T15:16:43.772Z Has data issue: false hasContentIssue false

Indeed, not really a brain disorder: Implications for reductionist accounts of addiction

Published online by Cambridge University Press:  06 March 2019

Matt Field
Affiliation:
Department of Psychology, University of Sheffield, Sheffield, S1 2LT, United Kingdommatt.field@sheffield.ac.ukhttps://www.sheffield.ac.uk/psychology/staff/academic/professor_matt_field
Nick Heather
Affiliation:
Department of Psychology, Northumbria University, Gosforth, Newcastle-upon-Tyne, NE3 1LU, United Kingdomnick.heather@unn.ac.ukhttps://www.northumbria.ac.uk/about-us/our-staff/h/nick-heather/
Reinout W. Wiers
Affiliation:
Department of Psychology, University of Amsterdam, PB 15916, 1001 NK Amsterdam, The Netherlands. r.wiers@uva.nlhttp://www.uva.nl/profiel/w/i/r.w.h.j.wiers/r.w.h.j.wiers.html

Abstract

Borsboom et al.’s formulation provides an opportunity for a fundamental rethink about the “brain disease model” of addiction that dominates research, treatment, policy, and lay understanding of addiction. We also demonstrate how the American opioid crisis provides a contemporary example of how “brain disease” is not moderated by the environmental context but is instead crucially dependent upon it.

Type
Open Peer Commentary
Copyright
Copyright © Cambridge University Press 2019 

The dominant explanation of addiction (substance-use disorder) is that it is an acquired brain disease (Leshner Reference Leshner1997; Volkow et. al Reference Volkow, Koob and McLellan2016). In recent years, many academic researchers, clinicians, and philosophers have objected to this characterization (e.g., Davies Reference Davies2018; Heather Reference Heather2018; Heather et al. Reference Heather, Best, Kawalek, Field, Lewis, Rotgers, Reinout and Heim2018; Levy Reference Levy2013; Lewis Reference Lewis2017; Satel & Lilienfeld Reference Satel and Lilienfeld2014). We commend Borsboom and colleagues for outlining a convincing alternative to biological reductionism as an explanation for mental and behavioral disorders. In this commentary, we outline how their approach provides the foundation for a fundamental rethink about the role of the brain in addiction, one that is able to retain many of the important contributions of neurobiological research to our understanding of the disorder without the requirement to accept the “greedy reductionism” (Dennett Reference Dennett1995) inherent in the “brain disease model of addiction” (Volkow et al. Reference Volkow, Koob and McLellan2016).

First, consideration of Borsboom et al.’s notions of rational relations and intentionality highlights the lack of explanatory power of the brain disease model of addiction. Current brain disease model of addiction accounts are able to characterise the molecular, structural, and functional adaptations in distinct brain regions that are correlated with distinct symptoms or “stages” of addiction, that is, multiple overlapping “brain diseases.” For example, Volkow et al. (Reference Volkow, Koob and McLellan2016) distinguish three recurring stages of addiction, each of which has a distinct neural substrate: (1) binge and intoxication, characterised by rapid learning about the incentive-motivational properties of the drug and associated cues; (2) withdrawal and negative affect, characterised by hyposensitivity of the brain reward system and an exaggerated stress response; and (3) preoccupation and anticipation, characterised by impaired decision-making and inability to resist strong urges.

Borsboom et al.’s notions of rational relations and intentionality can be applied to make sense of the addict's behaviour and how it is related to, but not fundamentally determined by, the underlying neurobiological changes. For example, regarding intentionality, within the “withdrawal and negative affect” stage, one must invoke intentionality in order to understand why the addict uses the drug to manage negative mood (because the drug has provided short-term relief in the past), and why medications that can alleviate withdrawal symptoms, such as nicotine replacement therapy or methadone, can reduce tobacco smoking and opiate use, respectively (Mattick et al. Reference Mattick, Breen, Kimber and Davoli2009; Stead et al. Reference Stead, Perera, Bullen, Mant, Hartmann-Boyce, Cahill and Lancaster2012). Regarding rational relations, to give one example, the observed “impaired control” over substance use seen in the “preoccupation and anticipation” stage (stage 3) can be understood as a direct consequence of increased valuation of the drug coupled with reduced valuation of alternatives (to drug use) that characterise stages 1 and 2, respectively (Berkman et al. Reference Berkman, Hutcherson, Livingston, Kahn and Inzlicht2017; Heyman Reference Heyman1996). Thus, there is no requirement to interpret the observed structural and functional changes in prefrontal brain regions as indicative of “impaired ability to resist strong urges” (Volkow et al. Reference Volkow, Koob and McLellan2016). Our point is that attempts to use neurobiological changes to explain behaviour can lead to very misleading explanations that are contradicted by behavioural data.

Second, consideration of intentionality can account for an important observation about the long-term course of addiction: Most addicts eventually recover from addiction, and most of those that recover do so without any treatment (Heyman Reference Heyman2013). If addiction is an acquired chronic brain disease, how can this be so? Demonstrations that addicts are less likely to recover if they believe that they suffer from a chronic disease (rather than, for example, an unhealthy habit that could be overcome; see Eiser & Van der Pligt Reference Eiser and Van der Pligt1986; Eiser et. al Reference Eiser, van der Pligt, Raw and Sutton1985; Miller et al. Reference Miller, Westerberg, Harris and Tonigan1996) make sense when viewed through Borsboom et al.’s framework: Addicts can change their behaviour and give up drugs, but only if their attributions for their addiction permit them to do so.

Finally, we suggest that the current “opioid crisis” in the United States provides a pertinent demonstration that addiction can be primarily determined by the broader social, environmental, cultural, and historical context (cf. Hart Reference Hart2013). The origins of this crisis coincided with the de-industrialization, economic decline, and urban decay in the “Rust Belt” and Appalachian regions (Quinones Reference Quinones2016). Together with alcohol poisonings, suicide, and chronic liver disease, increasing death rates from opioid overdose occurred among middle-aged, white, non-Hispanic men and women of low educational levels – the “deaths of despair” (Case & Deaton Reference Case and Deaton2015). There is also a strong inverse correlation between levels of “social capital” in United States counties and age-adjusted drug overdose mortality (Zoorob & Salemi Reference Zoorob and Salemi2017). More generally, there is evidence that deaths and emergency department visits related to opioid use vary with macroeconomic conditions (Hollingsworth et al. Reference Hollingsworth, Ruhm and Simon2017).

It could perhaps be argued that these variables exert their effects on rates of addiction merely by increasing the prevalence of drug use, so that more people are susceptible to the brain changes that then lead to the development of addiction. But in our view it is far more likely that the variables in question are significant elements in the kind of broad causal network that Borsboom et al. describe. For example, “people discover that opioids are an excellent short-term balm for existential maladies like self-loathing, emptiness, erosion of purpose, and isolation. Years of heavy use condition people to desire drugs at the first stab of distress” (Satel & Lilienfeld Reference Satel and Lilienfeld2017). So, too, the easy availability of opioids, whether by prescription from local medical practitioners or through the skillful marketing of illicit suppliers (Quinones Reference Quinones2016), make attempts at behavioral change less likely, and relapse (if change is attempted) more likely to occur. The overarching point is that these broad contextual determinants should be regarded as part of the casual nexus of the disorder of addiction, not merely as “social factors” that might moderate the expression of an underlying brain disease.

Acknowledgments

We thank Keith Humphreys and Sally Satel for useful comments on an earlier draft of this commentary, although responsibility for the final version is entirely our own.

References

Berkman, E. T., Hutcherson, C. A., Livingston, J. L., Kahn, L. E. & Inzlicht, M. (2017) Self-control as value-based choice. Current Directions in Psychological Science 26(5):422Google Scholar
Case, A. & Deaton, A. (2015) Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proceedings of the National Academy of Sciences USA 112(49):15078Google Scholar
Davies, J. (2018) Addiction is not a brain disease. (Editorial). Addiction Research and Theory 26(1):12.Google Scholar
Dennett, D. C. (1995) Darwin's dangerous idea: Evolution and the meanings of life. Penguin.Google Scholar
Eiser, J. R. & Van der Pligt, J. (1986) “Sick” or “hooked”: Smokers’ perceptions of their addiction. Addictive Behaviors 11(1):1115.Google Scholar
Eiser, J. R., van der Pligt, J., Raw, M. & Sutton, S. R. (1985) Trying to stop smoking: Effects of perceived addiction, attributions for failure, and expectancy of success. Journal of Behavioral Medicine 8(4):321–41.Google Scholar
Hart, C. (2013) High price: Drugs, neuroscience and discovering myself. Penguin.Google Scholar
Heather, N. (2018) Rethinking addiction. The Psychologist 31(1):2428.Google Scholar
Heather, N., Best, D., Kawalek, A., Field, M., Lewis, M., Rotgers, F., Reinout, W. & Heim, D. (2018) Challenging the brain disease model of addiction: European launch of the addiction theory network. (Editorial). Addiction Research and Theory 26(4):249–55. doi:10.1080/16066359.2017.1399659.Google Scholar
Heyman, G. M. (1996) Resolving the contradictions of addiction. Behavioral and Brain Sciences 19(4):561610.Google Scholar
Heyman, G. M. (2013) Quitting drugs: Quantitative and qualitative features. Annual Review of Clinical Psychology 9:2959.Google Scholar
Hollingsworth, A., Ruhm, C. & Simon, K. (2017) Macroeconomic conditions and opioid abuse. NBER Working Paper No. 23192. NBER Working Paper Series. National Bureau of Economic Research. Available at: http://www.nber.org/papers/w23192.Google Scholar
Leshner, A. (1997) Addiction is a brain disease, and it matters. Science 278(5335):4547.Google Scholar
Levy, N. (2013) Addiction is not a brain disease (and it matters). Frontiers in Psychiatry 4: article 24. (Online publication). doi: 10.3389/fpsyt.2013.00024 Available at: https://www.frontiersin.org/articles/10.3389/fpsyt.2013.00024/full.Google Scholar
Lewis, M. (2017) Addiction and the brain: Development, not disease. Neuroethics 10:718.Google Scholar
Mattick, R. P., Breen, C., Kimber, J. & Davoli, M. (2009) Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 3:CD002209. doi: 10.1002/14651858.CD002209.pub2.Google Scholar
Miller, W. R., Westerberg, V. S., Harris, R. J. & Tonigan, J. S. (1996) What predicts relapse? Prospective testing of antecedent models. Addiction 91(Suppl.):S15572.Google Scholar
Quinones, S. (2016) Dreamland: The true tale of America's opiate epidemic. Bloomsbury Press.Google Scholar
Satel, S. & Lilienfeld, S. (2014) Addiction and the brain-disease fallacy. Frontiers in Psychiatry 4: article 141. (Online publication). doi: 10.3389/fpsyt.2013.00141. Available at: https://www.frontiersin.org/articles/10.3389/fpsyt.2013.00141/full.Google Scholar
Satel, S. & Lilienfeld, S. (2017) Calling it “brain disease” makes addiction harder to treat. Boston Globe, June 22, 2017. Available at: https://www.bostonglobe.com/ideas/2017/06/22/calling-brain-disease-makes-addiction-harder-treat/ehaJs5ZYIXpPottG89KOGK/story.html.Google Scholar
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K. & Lancaster, T. (2012) Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 12:CD000146. doi: 10.1002/14651858.CD000146.pub4.Google Scholar
Volkow, N. D., Koob, G. F. & McLellan, A. T. (2016) Neurobiologic advances from the brain disease model of addiction. New England Journal of Medicine 374(4):363–71.Google Scholar
Zoorob, M. & Salemi, J. (2017) Bowling alone, dying together: The role of social capital in mitigating the drug overdose epidemic in the United States. Drug and Alcohol Dependence 173:19.Google Scholar